ArticleTherapeutic advances in chronic disease2024

Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: first interim analysis.

Annemieke M Boot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.